Workshop in Milan to Advance Expertise in Endometriosis and Adenomyosis-Related Infertility – ESHRE
European Society of Human Reproduction and Embryology (ESHRE) shared a post on LinkedIn:
“Less than Two Weeks and counting
Mark your calendar for 9–10 October in Milan, for this interactive ESHRE workshop designed to advance your clinical and research expertise in managing endometriosis and adenomyosis-related infertility.
This workshop will guide you through innovative approaches to assess and treat these complex conditions, with a focus on understanding underlying biological mechanisms and their impact on fertility. Gain practical strategies to implement evidence-based surgical and non-surgical interventions while developing personalised, patient-centered care plans.
Special sessions:
- Thursday: Keynote lecture: Neo-evolutionary-oriented theory on adenomyosis and endometriosis by Paolo Vercellini
- Friday: Poster session, highlighting the latest research and innovations
Earn 9,5 European CME credits
Organised by the ESHRE SIG Endometriosis and Endometrial Disorders.
Eager to join?”
-
Oct 11, 2025, 06:44The Global IVF Market Is Set to Reach $65B by 2032 – Meddilink
-
Dec 20, 2025, 10:57Clare Pin-Chia Huang: New Research Links Maternal Diabetes to Pregnancy Risks
-
Dec 20, 2025, 10:53Evaluating Maternal and Neonatal Health in Rheumatoid Arthritis Pregnancies – Hiroki Ozawa
-
Dec 20, 2025, 10:36Enhancing Care for Women Facing Recurrent Pregnancy Loss – SOGC
-
Dec 20, 2025, 05:00Ilana Ferhadian: Celebrating Book Launch
-
Dec 19, 2025, 16:21Launch of National Fertility Plan Marks Public Health Milestone – Collectif BAMP Association
-
Dec 18, 2025, 13:55Insights from Cendrine Siraudin on Fertility Support – Destination Santé
-
Dec 18, 2025, 13:34Alberto Sifuentes Giraldo: Key Insights on Antiphospholipid Syndrome From Recent Study
-
Dec 18, 2025, 13:28New Webinar on Managing Bipolar Disorder in Perinatal Patients – The Periscope Project Perinatal Specialty Consult Psychiatry
-
Dec 18, 2025, 13:16New Score Quantifying Disease Activity in Patients With Antiphospholipid Syndrome – EULAR
